Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.
about
Endothelial PPAR-γ Protects Against Vascular Thrombosis by Downregulating P-Selectin ExpressionSignificanceGenetic Regulation of Endothelial Vasomotor FunctionContrasting vascular effects caused by loss of Bardet-Biedl syndrome genes.Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In VivoEndothelial and vascular muscle PPARgamma in arterial pressure regulation: lessons from genetic interference and deficiency.Vascular smooth muscle cell-selective peroxisome proliferator-activated receptor-gamma deletion leads to hypotensionBioinformatic analysis of gene sets regulated by ligand-activated and dominant-negative peroxisome proliferator-activated receptor gamma in mouse aorta.Role of vascular smooth muscle PPARγ in regulating AT1 receptor signaling and angiotensin II-dependent hypertension.Interference with peroxisome proliferator-activated receptor-γ in vascular smooth muscle causes baroreflex impairment and autonomic dysfunction.Genetic interference with peroxisome proliferator-activated receptor γ in smooth muscle enhances myogenic tone in the cerebrovasculature via A Rho kinase-dependent mechanism.Protecting against vascular disease in brainPeroxisome proliferator-activated receptor-γ regulates inflammation and renin-angiotensin system activity in the hypothalamic paraventricular nucleus and ameliorates peripheral manifestations of heart failure.Uncoupling of eNOS causes superoxide anion production and impairs NO signaling in the cerebral microvessels of hph-1 mice.Cullin-3 regulates vascular smooth muscle function and arterial blood pressure via PPARγ and RhoA/Rho-kinase.Interference with PPARγ in endothelium accelerates angiotensin II-induced endothelial dysfunction.Small-molecule inhibitors of signal transducer and activator of transcription 3 protect against angiotensin II-induced vascular dysfunction and hypertensionEndothelial PPAR-γ provides vascular protection from IL-1β-induced oxidative stressThe adaptation of the cerebral circulation to pregnancy: mechanisms and consequencesDominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscleMicrovascular Dysfunction and Cognitive Impairment.Early effects of high-fat diet on neurovascular function and focal ischemic brain injury.PPARgamma in the endothelium regulates metabolic responses to high-fat diet in miceEffect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance.Significant synergistic effect of peroxisome proliferator-activated receptor gamma C-2821T and diabetes on the risk of ischemic stroke.Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production.Does peroxisome proliferator-activated receptor-gamma (PPAR gamma) protect from hypertension directly through effects in the vasculature?Retinol-binding protein 7 is an endothelium-specific PPARγ cofactor mediating an antioxidant response through adiponectin.Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.PPARγ agonist beyond glucose lowering effect.Molecular mechanisms regulating vascular tone by peroxisome proliferator activated receptor gamma.PPARγ Regulation in Hypertension and Metabolic Syndrome.Friend or foe? Telomerase as a pharmacological target in cancer and cardiovascular disease.Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke.AT1 receptor signaling pathways in the cardiovascular system.The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice.A clinical link between peroxisome proliferator-activated receptor γ and the renin-angiotensin system.Restoration of Endothelial Function in Pparα (-/-) Mice by Tempol.Surviving the remodel: the impact of hypertension during pregnancy.A second chance for a PPARγ targeted therapy?PPARγ: no SirT, no service.
P2860
Q27342480-045E2189-8511-4931-8DFD-78427BA03287Q28073934-CC17D4BB-F921-465F-BD09-BA5AC8B4741CQ29347284-B4AC1556-2F96-4AD5-BD39-F999D9F3A40EQ30300042-901D7811-0521-44A9-9498-505FC8A4BAFCQ33642053-51565EFF-AA8D-40BA-86E7-9A556F7386C8Q33692662-5105DFFE-AA40-4CA4-8792-CCD269327875Q33772466-9DBFDD8A-D33C-42D6-9D92-F962BC42BFB2Q34046462-D288696B-3C21-49E5-8058-5A02AE093A40Q34051403-C5BFDCE3-6711-4CBC-9111-1FEB92E17555Q34892807-AF4942D8-A66E-40C4-8E1B-0BBED31C6454Q34979773-98F510EC-C2BC-4335-8390-66D1838946DEQ35696867-5FD12ECA-F69D-4DCC-9A84-3F99D1AD8B20Q36208091-99139B53-D4EE-46D2-99C4-232E78D149EEQ36328405-4488CEA5-9D80-42B8-BDC3-B6224B408270Q36510633-EC1E8F35-9FD9-48D5-8A8E-AE800CA8A6B6Q36660171-7BB0EB2D-8B61-4C00-955E-5143A4B912F9Q36699263-8E3CBC34-877A-4E40-93FD-D6F385B84FC6Q36745113-EE216ED0-858E-4D99-AEC2-6BB45541E25DQ36837948-D1B7807A-D608-439F-9F1E-0FAD5680C63CQ36839870-79B237D1-40BE-4752-B1EA-D243ADF9153FQ36923873-AB62CC83-DE69-41DD-8D67-CEB4C75F98B9Q37036060-528266BE-AE52-4132-9D3C-C67CD28EE625Q37139680-3E8E83C1-771F-4871-AC8C-F4D817F8A833Q37400909-6BDC601E-EBE0-4C99-8864-9965A35B2C1CQ37430999-EB917DBA-C363-4CF6-BF1E-43254323A396Q37686890-98E54C68-42C9-448E-8532-029442340170Q37711778-373EE50F-73C1-4CC4-B402-EF431F0342E9Q37725077-3C1EFC95-D7CC-4EC5-BB06-B6016337FE7FQ37857704-600047C0-6463-4D04-9908-053CE9B97AC1Q38318147-D1305A9C-B556-47FD-85BF-EA962AF39CBAQ38606230-1E7388AD-4689-43CD-8220-6D3CE075E838Q38890930-D8EA01F5-E658-4905-BE33-8AD7AF66A500Q39116577-150311BF-6EFB-47DE-92BC-17C0E23D7CA8Q39319793-87C3E59C-7C7F-415B-8D75-1B43E370BE5EQ42452192-C520F662-EC42-49E9-95F7-2759C4D9219EQ42728134-A553818B-91C8-4EAD-867A-859DAD92CB19Q42787829-AF5E465D-2C91-4FBA-924F-71A095D86780Q42794846-6BF1FC24-9B00-439E-9057-77D3082C7F00Q43100241-13775748-2C10-41FA-B235-3C33B77B864AQ43240954-74AAD7A6-A300-43AC-B108-447D9C884A72
P2860
Endothelium-specific interference with peroxisome proliferator activated receptor gamma causes cerebral vascular dysfunction in response to a high-fat diet.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Endothelium-specific interfere ...... n response to a high-fat diet.
@en
type
label
Endothelium-specific interfere ...... n response to a high-fat diet.
@en
prefLabel
Endothelium-specific interfere ...... n response to a high-fat diet.
@en
P2093
P2860
P1433
P1476
Endothelium-specific interfere ...... in response to a high-fat diet
@en
P2093
Andreas M Beyer
Frank M Faraci
Henry L Keen
Mary L Modrick
Willem J de Lange
P2860
P304
P356
10.1161/CIRCRESAHA.108.176339
P577
2008-07-31T00:00:00Z